Eteplirsen OverviewEteplirsen (brand name Exondys 51) is a medication to treat, but not cure, some types of Duchenne muscular dystrophy (DMD), caused by a specific mutation. Eteplirsen only targets specific mutations and is useful in about 14% of cases. Eteplirsen was designed and developed by Sarepta Therapeutics. After a controversial debate surrounding the efficacy of the drug, during which two FDA review panel members resigned in protest, eteplirsen received accelerated...
Read more Eteplirsen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eteplirsen
Recent Eteplirsen Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 100mg/2ml (50mg/ml), 500mg/10ml (50mg/ml)
Other drugs which contain Eteplirsen or a similar ingredient: (1 result)
- EXONDYS 51 Eteplirsen